News about Global Pharma

Gates Foundation Gives USD 2.5 Million Grant to Evotec for Advancement of TB Treatment

Evotec will utilise the USD 2.5 million grants awarded by the Gates Foundation for the future development of drugs to treat tuberculosis.

Global Pharma | 08/05/2025 | By Manvi |  438

Lupin Launches Eslicarbazepine Acetate Tablets in the United States

Lupin has launched its US FDA-approved generic Eslicarbazepine Acetate Tablets in 200 mg, 400 mg, 600 mg, and 800 mg strengths in the US.

Global Pharma | 07/05/2025 | By Manvi |  256

SK bioscience Chosen for KDCA's Pandemic Preparedness R&D Program

SK bioscience announced that it has been selected for the Korea Disease Control and Prevention Agency (KDCA)'s Priority Infectious Disease Pandemic Preparedness Rapid R&D Support Program.

Global Pharma | 07/05/2025 | By Manvi |  166

AliveCor Launches AI-Powered KardiaMobile 6L Max with Smart Heart Alerts

With KardiaMobile 6L Max and KardiaAlert, users gain access to technology and tools that offer more detections and insights, monitor heart rhythm for potential changes over time, and alert patients–helping them take action.

Global Pharma | 07/05/2025 | By Manvi |  322

Gautam Shah Takes Over as President US Operations of Senores Pharmaceuticals

US subsidiary of Senores Pharmaceuticals, Havix Group Inc. D/B/A Aavis Pharmaceuticals, with the appointment of Gautam Shah as President of US Operations plans to scale new heights and expand their business

Global Pharma | 07/05/2025 | By Manvi |  249

IDEAYA Biosciences Secures US FDA IND-Clearance for IDE849

IDEAYA Biosciences has received FDA clearance to initiate a Phase 1 trial of IDE849, a potential first-in-class DLL3-targeting antibody-drug conjugate for advanced solid tumours, including small cell lung cancer.

Global Pharma | 06/05/2025 | By Manvi |  353

Senores Pharmaceuticals Acquires ANDA for Topiramate Tablets from Wockhardt

Senores Pharmaceuticals Ltd., via its US subsidiary, has acquired the USFDA-approved ANDA for Topiramate tablets from Wockhardt Ltd., marking a strategic expansion into the USD 111 million US epilepsy and migraine drug market.

Global Pharma | 06/05/2025 | By Manvi |  583

Human Longevity Adds Avantect Test to Boost Early Pancreatic Cancer Detection

This groundbreaking DNA-based blood test is designed to detect early-stage pancreatic cancer. When integrated with HLI's proprietary whole genome sequencing platform and cutting-edge MRI imaging, it offers one of the most advanced early cancer detection strategies available today.

Global Pharma | 06/05/2025 | By Manvi |  181

FDA Lists Leo Cancer Care's Marie Particle Therapy System as Pending

The Food and Drug Administration Agency (FDA) has updated the regulatory status of Marie®, Leo Cancer Care's upright particle therapy solution, to pending. Marie combines Leo Cancer Care's upright patient positioning system with their upright fan beam CT scanner and can be utilized with any fixed particle beam.

Global Pharma | 06/05/2025 | By Manvi |  381

Biocon Biologics Secures Market Access Coverage for Yesintek in United States

Biocon Biologics has secured market access agreements covering over 100 million lives in the US for Yesintek, its FDA-approved biosimilar to Stelara, marking a major milestone in its US biosimilars launch.

Global Pharma | 05/05/2025 | By Manvi |  233